Shield Therapeutics plc
SHIEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $40,111 | $27,031 | $13,602 | $48,730 |
| - Cash | $10,814 | $6,524 | $8,099 | $0 |
| + Debt | $27,048 | $26,370 | $19,971 | $0 |
| Enterprise Value | $56,345 | $46,877 | $25,474 | $48,730 |
| Revenue | $15,625 | $7,497 | $4,807 | $3,586 |
| % Growth | 108.4% | 56% | 34% | – |
| Gross Profit | $7,713 | $3,543 | $2,162 | $729 |
| % Margin | 49.4% | 47.3% | 45% | 20.3% |
| EBITDA | -$3,971 | -$3,193 | -$5,332 | -$8,063 |
| % Margin | -25.4% | -42.6% | -110.9% | -224.8% |
| Net Income | -$6,947 | -$4,377 | -$6,133 | -$8,479 |
| % Margin | -44.5% | -58.4% | -127.6% | -236.4% |
| EPS Diluted | -0.007 | -0.006 | -0.008 | -0.011 |
| % Growth | -17.9% | 28.2% | 31.6% | – |
| Operating Cash Flow | $6,016 | -$1,199 | -$1,413 | -$7,061 |
| Capital Expenditures | $0 | -$0 | -$13 | -$25 |
| Free Cash Flow | $6,016 | -$1,199 | -$1,426 | -$7,086 |